Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1401-1410 of 1,472) with videos related to

Pageof 148
Sort By:
The Journal of Experimental Medicine|October 12, 2020
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodelingCarmine Fedele, Shuai Li, Kai Wen Teng, et al.
Nature Genetics|April 11, 2017
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virusM Azim Ansari, Vincent Pedergnana, Camilla L C Ip, et al.
Journal of Inorganic Biochemistry|November 13, 2019
Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligandStephen J Beebe, Michael J Celestine, Jimmie L Bullock, et al.
Cell Metabolism|November 4, 2020
Pyruvate Kinase Controls Signal Strength in the Insulin Secretory PathwaySophie L Lewandowski, Rebecca L Cardone, Hannah R Foster, et al.
Bioelectromagnetics|February 27, 2025
Recent Advances and Future Perspective in Computational Bioelectromagnetics for Exposure AssessmentsYinliang Diao, Wout Joseph, Dragan Poljak, et al.
Hepatology (Baltimore, Md.)|February 24, 2018
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trialGraham R Foster, Kosh Agarwal, Matthew E Cramp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisRobert W Wilkinson, Rajesh Odedra, Simon P Heaton, et al.
BMC Infectious Diseases|June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyEvan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Addiction (Abingdon, England)|January 30, 2019
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in EnglandGraham I Harrison, Karen Murray, Roxanne Gore, et al.
Journal of Viral Hepatitis|March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinG R Foster, S Zeuzem, S Pianko, et al.
Pageof 148

Showing results (1401-1410 of 1,472) with videos related to

Sort By:
Pageof 148
The Journal of Experimental Medicine|October 12, 2020
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodelingCarmine Fedele, Shuai Li, Kai Wen Teng, et al.
Nature Genetics|April 11, 2017
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virusM Azim Ansari, Vincent Pedergnana, Camilla L C Ip, et al.
Journal of Inorganic Biochemistry|November 13, 2019
Synthesis, characterization, DNA binding, topoisomerase inhibition, and apoptosis induction studies of a novel cobalt(III) complex with a thiosemicarbazone ligandStephen J Beebe, Michael J Celestine, Jimmie L Bullock, et al.
Cell Metabolism|November 4, 2020
Pyruvate Kinase Controls Signal Strength in the Insulin Secretory PathwaySophie L Lewandowski, Rebecca L Cardone, Hannah R Foster, et al.
Bioelectromagnetics|February 27, 2025
Recent Advances and Future Perspective in Computational Bioelectromagnetics for Exposure AssessmentsYinliang Diao, Wout Joseph, Dragan Poljak, et al.
Hepatology (Baltimore, Md.)|February 24, 2018
Elbasvir/grazoprevir and sofosbuvir for hepatitis C virus genotype 3 infection with compensated cirrhosis: A randomized trialGraham R Foster, Kosh Agarwal, Matthew E Cramp, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisRobert W Wilkinson, Rajesh Odedra, Simon P Heaton, et al.
BMC Infectious Diseases|June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE studyEvan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Addiction (Abingdon, England)|January 30, 2019
The Hepatitis C Awareness Through to Treatment (HepCATT) study: improving the cascade of care for hepatitis C virus-infected people who inject drugs in EnglandGraham I Harrison, Karen Murray, Roxanne Gore, et al.
Journal of Viral Hepatitis|March 16, 2013
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirinG R Foster, S Zeuzem, S Pianko, et al.
Pageof 148